With the changing disease spectrum, atherosclerosis has become increasingly prevalent
worldwide and the associated diseases have emerged as the leading cause of death. Due …

Cardiovascular diseases have become the major killers in today's world, among which
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …

Fluorescent probes capable of precise detection of atherosclerosis (AS) at an early stage
and fast assessment of anti‐AS drugs in animal level are particularly valuable. Herein, a …

Multifunctional nanoplatforms combined with photodynamic therapy (PDT) and anticancer
drugs have shown great promising in cancer therapy. However, their efficacy is limited by …

Nanoparticle-based therapy has gained much attention in the pharmaceutical industry.
Fucoidan is a sulfated polysaccharide naturally derived from marine brown algae and is …

Chitosan (CS) electrospun nanofiber (ENF) membranes were modified with fucoidan (Fu)
and CuS NPs through polyelectrolyte complexation and genipin (GP)-involved cross-linking …

Atherosclerosis is a chronic inflammatory disease involved in plaque rupture, stroke,
thrombosis, and heart attack (myocardial infarction), which is a leading cause of sudden …

Coronary heart disease (CHD) is one of the major causes of death and disability worldwide,
especially in low-and middle-income countries and among older populations. Conventional …

Fucoidan is a sulfated polysaccharide with various bioactivities. The application of fucoidan
in cancer treatment, wound healing, and food industry has been extensively studied …

The marine polysaccharide fucoidan (FUC) is a promising polymer for pharmaceutical
research and development of novel drug delivery systems with modified release and …